Foresight News reports that Bio Protocol has announced that the Ignition Sale public offering for the biotechnology project Aubrai was oversubscribed by six times within just a few hours of its launch.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.